Calling a delay in approval of a sunscreen product by the U.S Food and Drug Administration “unconscionable,” Sen. Sherrod Brown yesterday urged passage of a bill requring the agency to review its entire list of pending sunscreen applications within eight months of the bill being signed into law.
In a conference call with Ohio reporters, Brown, D-Ohio, said the FDA has delayed approval of production by an Ohio company of a key ingredient used in sunscreen. That company, Ashland Inc., has a factory in Columbus and it expanded the facility hoping the FDA would approve its application. Ashland is allowed to sell the ingredient for sunscreen in Canada and the European Union.
To read the full article, click the link below.